Media enquiries.
Support for media coverage.
Our team can help with media requests directly related to BioSymetrics and its work, including interview requests, expert commentary, company and research background, and speaking opportunities.
About BioSymetrics.
BioSymetrics is a biology-first, AI-powered drug discovery and data analytics company that combines clinical data, machine learning, and experimental biology to identify disease subgroups, biomarkers, and therapeutic targets. Its translational approach connects patterns in human disease with phenotypes measured in experimental models and tests selected hypotheses through biological validation. BioSymetrics also applies phenotypic screening and mechanism-of-action analysis to chemical threat assessment. For more information, visit biosymetrics.com.
Have a media enquiry about BioSymetrics?
Contact Aysha Rashid, Business Development Lead, at . We respond to media enquiries within one to three business days.